MIRA Pharmaceuticals, Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
MIRA Pharmaceuticals, Inc. (MIRA) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $171.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2026-08-12
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $171.00K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $10.31K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $54.00K.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $400.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $171.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $10.31K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $54.00K 10-K · filed 2026-03-31 |
| 2025-03-31 | $400.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.50M 10-K · filed 2025-03-28 |
| 2024-09-30 | $500.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $900.00K 10-Q/A · filed 2024-08-16 |
| 2024-03-31 | $1.60M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.30M 10-K · filed 2024-04-01 |
| 2023-09-30 | $1.50M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.70M 10-Q · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |